Rosetta Genomics Ltd.
ROSG
ROSG was delisted on the 21st of May, 2018.
10 hedge funds and large institutions have $1.11M invested in Rosetta Genomics Ltd. in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
9% more capital invested
Capital invested by funds: $1.01M → $1.11M (+$96K)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$62.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$49.8K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.12K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$1.2K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$199 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$41.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$28K |
| 3 |
HCM
Highlander Capital Management
Short Hills,
New Jersey
|
-$7.24K |
| 4 |
ICAS
Investors Capital Advisory Services
Lynnfield,
Massachusetts
|
-$940 |
| 5 |
Citigroup
New York
|
-$299 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Highlander Capital Management
Short Hills,
New Jersey
| $595K | -$7.24K | -508 | -1% |
|
|
2
Morgan Stanley
New York
| $338K | +$62.6K | +4,397 | +22% |
|
3
California Public Employees Retirement System
Sacramento,
California
| $58K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $49K | +$49.8K | +3,493 | +7,277% |
|
|
VKH
5
Virtu KCG Holdings
New York
| $29K | -$41.7K | -2,926 | -58% |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $25K | +$8.12K | +570 | +47% |
|
|
ICAS
7
Investors Capital Advisory Services
Lynnfield,
Massachusetts
| $12K | -$940 | -66 | -7% |
|
|
8
Wells Fargo
San Francisco,
California
| $2K | +$1.2K | +84 | +101% |
|
|
9
Citigroup
New York
| $1K | -$299 | -21 | -20% |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$28K | -2,161 | Closed |
|
|
11
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | +$199 | +14 | New |
|
ROSG Hedge Fund Activity: Q2 2016 in Review
10 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics Ltd. (ROSG) for Q2 2016, worth a combined $1.11M — up 9.5% from $1.01M a quarter earlier.
Fund positioning in ROSG was balanced in Q2 2016: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 4 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $62.6K. The largest seller was Virtu KCG Holdings, cutting an estimated $41.7K.
- 10 institutional investors held Rosetta Genomics Ltd. (ROSG) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $1.11M of Rosetta Genomics Ltd. stock for Q2 2016, up 9.5% quarter-over-quarter.
- 1 fund opened new Rosetta Genomics Ltd. positions in Q2 2016 and 1 closed out, a net change of 0 holders.
- The largest Rosetta Genomics Ltd. buyer in Q2 2016 was Morgan Stanley, an estimated $62.6K added.
- The largest Rosetta Genomics Ltd. seller in Q2 2016 was Virtu KCG Holdings, an estimated $41.7K sold.
Based on aggregated 13F filings for Q2 2016.